0 Комментарии
0 Поделились
311 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Meningococcal Disease Vaccine Market: Insights and Competitive AnalysisExecutive Summary Meningococcal Disease Vaccine Market Size and Share Forecast CAGR Value Global meningococcal disease vaccine market size was valued at USD 4.10 billion in 2024 and is projected to reach USD 8.79 billion by 2032, with a CAGR of 10.00% during the forecast period of 2025 to 2032. By considering a definite base year and historic year, calculations in the Meningococcal...0 Комментарии 0 Поделились 383 Просмотры 0 предпросмотр
-
Meningococcal Disease Vaccine Market: Insights, Key Players, and Growth AnalysisExecutive Summary Meningococcal Disease Vaccine Market: Growth Trends and Share Breakdown CAGR Value Global meningococcal disease vaccine market size was valued at USD 4.10 billion in 2024 and is projected to reach USD 8.79 billion by 2032, with a CAGR of 10.00% during the forecast period of 2025 to 2032. In this competitive marketplace, businesses are always in struggle to seek better...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Meningococcal Disease Vaccine Market: Insights, Key Players, and Growth AnalysisAccording to the latest report published by Data Bridge Market Research, the Meningococcal Disease Vaccine Market CAGR Value Global meningococcal disease vaccine market size was valued at USD 4.10 billion in 2024 and is projected to reach USD 8.79 billion by 2032, with a CAGR of 10.00% during the forecast period of 2025 to 2032. The Meningococcal Disease...0 Комментарии 0 Поделились 215 Просмотры 0 предпросмотр
-
Meningococcal Polysaccharide Vaccine Market to Reach USD 4.5 Billion by 2030 | CAGR 6.3%According to a newly published market research report by 24LifeSciences, global meningococcal polysaccharide vaccine market was valued at USD 2.8 billion in 2023 and is projected to reach USD 4.5 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.3% during the forecast period 2024-2030. Meningococcal polysaccharide vaccines are immunogenic preparations...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр